PMID: 6573691Mar 1, 1983Paper

The antiarrhythmic effect of PGE2 on premature ventricular beats (PVBs) in man

Prostaglandins, Leukotrienes, and Medicine
H J Mest, J Rausch


In 10 patients with premature ventricular beats (PVBs) we investigated the influence of PGE2 infusion on ventricular arrhythmias, arterial blood pressure, heart rate and systolic time intervals. An infusion of PGE2 in doses of 0.01, 0.02 and 0.04 microgram/kg/min, each for 10 min, did not change the blood pressure, heart rate and systolic time intervals. The incidence of PVBs decreased in a dose-dependent manner in 7 out of 10 patients, and in two of them PVBs were absolutely abolished. In one patient the incidence of PVBs was reduced dose independently, and in two patients at the beginning of infusion of PGE2 the incidence of PVBs was reduced, but the incidence of PVBs increased again although the infusion dose was doubled. In all patients the incidence of PVBs increased again when the infusion of PGE2 was stopped. Our findings demonstrate that PGE2 has antiarrhythmic properties in man.


Jul 1, 1971·Cardiovascular Research·S M KarimK Hillier
Feb 1, 1968·Circulation·A M WeisslerC D Schoenfeld
Jul 1, 1981·American Heart Journal·D N MohrJ E Markis

Related Concepts

Cardiac Arrhythmia
Diastolic Blood Pressure
Dose-Response Relationship, Drug
Pulse Rate
Left Ventricular Structure
Prostaglandins E

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.